Activation of human dendritic cells by bacillus Calmette-Guerin

被引:27
作者
Ramoner, R [1 ]
Rieser, C
Herold, M
Klocker, H
Bartsch, G
Stenzl, A
Thurnher, M
机构
[1] Univ Innsbruck, Dept Urol, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Dept Internal Med, A-6020 Innsbruck, Austria
基金
奥地利科学基金会;
关键词
dendritic cells; mycobacterium bovus; interleukin-8;
D O I
10.1097/00005392-199805000-00021
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Dendritic cells are the most potent antigen presenting cells capable of initiating antitumor immune responses. We previously showed that bacillus Calmette-Guerin (BCG) stimulates cultured human dendritic cells. We extended these studies and tested the ability of cultured human dendritic cells to express interleukin IL-8 in response to BCG. We also investigated the T cell stimulatory potential of BCG treated dendritic cells in mixed leukocyte reactions. Materials and Methods: Dendritic cells were obtained by culturing plastic adherent mononuclear cells from peripheral blood for 6 days in the presence of granulocyte-macrophage colony-stimulating factor and IL-4. Spontaneous and BCG stimulated IL-8 protein release into culture supernatants was measured by a quantitative immunoassay. IL-8 gene transcription was assessed by reverse transcription-polymerase chain reaction. Untreated and BCG exposed dendritic cells were compared as stimulators of allogeneic T cell proliferation, measured as [H-3]thymidine incorporation. Results: BCG stimulated IL-8 messenger ribonucleic acid expression and IL-8 protein release. IL-8 secretion occurred in a dose and time dependent fashion. BCG induced IL-8 release was further enhanced in the presence of indomethacin. BCG treated dendritic cells were much more potent T cell stimulators than untreated dendritic cells. Conclusions: These data demonstrate that BCG enhances the production of IL-8, a potent chemokine of T cells and granulocytes, as well as the T cell stimulatory potential of human dendritic cells.
引用
收藏
页码:1488 / 1492
页数:5
相关论文
共 23 条
  • [2] Origin, maturation and antigen presenting function of dendritic cells
    Cella, M
    Sallusto, F
    Lanzavecchia, A
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) : 10 - 16
  • [3] CHRISTMAS TJ, 1992, CLIN EXP IMMUNOL, V87, P450
  • [4] DEKERNION JB, 1990, IMMUNOTHERAPY UROLOG, P1
  • [5] GALLAND MB, 1991, EUR UROL, V19, P171
  • [6] Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
    Hsu, FJ
    Benike, C
    Fagnoni, F
    Liles, TM
    Czerwinski, D
    Taidi, B
    Engleman, EG
    Levy, R
    [J]. NATURE MEDICINE, 1996, 2 (01) : 52 - 58
  • [7] DISTRIBUTION OF S-100 PROTEIN-POSITIVE DENDRITIC CELLS AND EXPRESSION OF HLA-DR ANTIGEN IN TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER IN RELATION TO TUMOR PROGRESSION AND PROGNOSIS
    INOUE, K
    FURIHATA, M
    OHTSUKI, Y
    FUJITA, Y
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1993, 422 (05) : 351 - 355
  • [8] ELEVATED INTERLEUKIN-8 LEVELS IN THE URINE OF PATIENTS WITH URINARY-TRACT INFECTIONS
    KO, YC
    MUKAIDA, N
    ISHIYAMA, S
    TOKUE, A
    KAWAI, T
    MATSUSHIMA, K
    KASAHARA, T
    [J]. INFECTION AND IMMUNITY, 1993, 61 (04) : 1307 - 1314
  • [9] MOLECULAR-CLONING OF A HUMAN MONOCYTE-DERIVED NEUTROPHIL CHEMOTACTIC FACTOR (MDNCF) AND THE INDUCTION OF MDNCF MESSENGER-RNA BY INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR
    MATSUSHIMA, K
    MORISHITA, K
    YOSHIMURA, T
    LAVU, S
    KOBAYASHI, Y
    LEW, W
    APPELLA, E
    KUNG, HF
    LEONARD, EJ
    OPPENHEIM, JJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (06) : 1883 - 1893
  • [10] BONE-MARROW-DERIVED DENDRITIC CELLS PULSED WITH SYNTHETIC TUMOR PEPTIDES ELICIT PROTECTIVE AND THERAPEUTIC ANTITUMOR IMMUNITY
    MAYORDOMO, JI
    ZORINA, T
    STORKUS, WJ
    ZITVOGEL, L
    CELLUZZI, C
    FALO, LD
    MELIEF, CJ
    ILDSTAD, ST
    KAST, WM
    DELEO, AB
    LOTZE, MT
    [J]. NATURE MEDICINE, 1995, 1 (12) : 1297 - 1302